You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 245 No. 15, April 17, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  CLINICAL NOTES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Rapidly Expanding Pulmonary Nodule Caused by Pittsburgh Pneumonia Agent

A. Robin Ellis, MD; Douglas L. Mayers, MD; William J. Martone, MD; Barbara L. Mitchell, MS; Nuzhet O. Atuk, MD; Richard L. Guerrant, MD

JAMA. 1981;245(15):1558-1559.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

PITTSBURGH pneumonia agent (PPA), also known as TATLOCK and HEBA, and tentatively ascribed to the genus Legionella (L micdadei), has recently been identified as a cause of pneumonia in patients receiving high-dose steroid therapy for rejection of renal transplants.1-4 We report a case of a rapidly expanding pulmonary nodule caused by PPA in an immunosuppressed renal transplant patient.

Report of a Case

A 59-year-old man had a cadaveric renal transplantation because of renal failure caused by familial polycystic kidney disease. After transplantation, he was given prednisone, 2 mg/kg/day, and azathioprine, 3 mg/kg/day. During the next six weeks of hospitalization, he had four episodes of acute graft rejection, each treated with methylprednisolone sodium succinate pulse therapy, 30 to 90 mg/kg/day for three days. He was discharged from the hospital with instructions to take prednisone, 70 mg/day, and azathioprine, 50 mg/day, but was readmitted one week later for a rising serum . . . [Full Text PDF of this Article]


Author Affiliations

From the Departments of Internal Medicine (Drs Ellis, Mayers, Martone, Atuk, and Guerrant) and Clinical Pathology (Ms Mitchell), University of Virginia Medical Center, Charlottesville; and the Bureau of Epidemiology, Centers for Disease Control, Atlanta (Dr Martone).


Footnotes

Reprint requests to Department of Internal Medicine, Box 485, School of Medicine, University of Virginia, Charlottesville, VA 22908 (Dr Guerrant).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.